PET-MF,
Showing 1 - 25 of 4,962
Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Polycythemia Vera
-
Phoenix, Arizona
- +4 more
Jun 20, 2022
Idiopathic Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia-Vera Myelofibrosis Trial in Worldwide
Completed
- Idiopathic Myelofibrosis
- +2 more
-
Paris, France
- +9 more
Jun 22, 2021
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by
Recruiting
- Myocardial Ischemia
- +7 more
- Myocardial Perfusion Imaging Study
- AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION [Ammonia N 13]
-
Miami, Florida
- +3 more
Jan 4, 2023
Serial PET MPI in Patients Undergoing Cancer Treatment
Enrolling by invitation
- Cancer
- +3 more
-
Los Angeles, CaliforniaWest Los Angeles VA Medical Center
Jun 12, 2023
Normal Healthy Volunteers Without Chronic Medical Conditions, Coronary Artery Disease, Cardiac Risk Factors Trial in New Orleans
Completed
- Normal Healthy Volunteers Without Chronic Medical Conditions
- +3 more
- Slow Infusion of Rubidium-82
-
New Orleans, LouisianaOchsner
Jan 16, 2023
Relapsed or Refractory CD30+ Malignancies When Re-treated With
Completed
- Hodgkin Disease
- Lymphoma, T-Cell, Cutaneous
- No Intervention
-
San Bartolome, Alicante, Spain
- +29 more
Jul 28, 2022
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Recruiting
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Physician's Choice medications
-
Birmingham, Alabama
- +151 more
Aug 22, 2022
Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1
Recruiting
- Schizophrenia
- +2 more
- 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
-
New Haven, ConnecticutConnecticut Mental Health Center
Sep 16, 2022
Long-term Evaluation
Recruiting
- Atherosclerosis
- +3 more
- PET imaging
- +2 more
-
Cambridge, United KingdomUniversity of Cambridge
Mar 18, 2022
Sex and Obesity: Effects on Heart Failure Study
Active, not recruiting
- Obesity
- Heart Failure
- PET (positron Emission Tomography)
- +7 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 30, 2023
Different Sonographic Modalities and PET-CT in Pediatric
Not yet recruiting
- Pediatric Lymphoma
- ultrasonography
- (no location specified)
Apr 22, 2022
Response to Gemcitabine Chemotherapy in Mycosis Fungoides
Recruiting
- Lymphoma, T-Cell, Cutaneous
- Mycosis Fungoides
- single-arm, non-randomized Biodynamic imaging (BDI)
-
Indianapolis, IndianaIndiana University School of Medicine, Department of Dermatology
Nov 16, 2022
Inpatient Evaluation of Adults With Schizophrenia
Recruiting
- Schizophrenia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))
Recruiting
- High Grade Glioma
- +12 more
- LUTATHERA® (Lutetium Lu 177 dotatate)
-
Aurora, Colorado
- +8 more
Jan 16, 2023
Assess the Safety of Fedratinib in Korean Myelofibrosis
Recruiting
- Primary Myelofibrosis
- +2 more
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or
Terminated
- Ovarian Cancer
- Ovarian Neoplasms
- 18F-EF5 PET/CT scan
- Optional biopsy
-
Vancouver, British Columbia, CanadaBC Cancer Agency - Vancouver Centre
Feb 2, 2022